Patents by Inventor Brendan J. R. Whittle

Brendan J. R. Whittle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5028628
    Abstract: The present invention is concerned with methods for the treatment and diagnosis of pulmonary hypertension which comprise the administration of an effective amount of a compound of formula (I) ##STR1## wherein X is hydrogen or methyl;Y is --O-- or --CH.sub.2 --;R is --C(R.sup.1)(R.sup.2)CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3 wherein R.sup.1 and R.sup.2, which may be the same or different, are selected from hydrogen and halogen; andthe dotted line represents an optional double bond; andpharmaceutically acceptable salts and acid derivatives thereof.Medicaments and diagnostic aids for use in the methods of the invention are also within the scope of the invention.
    Type: Grant
    Filed: October 13, 1989
    Date of Patent: July 2, 1991
    Assignee: Burroughs Wellcome Co.
    Inventors: Anjaneyulu S. Tadepalli, Brendan J. R. Whittle
  • Patent number: 4839169
    Abstract: A combination of t-PA and a prostaglandin of use in removing or inhibiting the formation of a blood clot in a mammal.
    Type: Grant
    Filed: August 4, 1987
    Date of Patent: June 13, 1989
    Assignee: Burroughs Wellcome Co.
    Inventor: Brendan J. R. Whittle